145 related articles for article (PubMed ID: 18621634)
1. Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques.
Sullivan CA; Chung GG
Clin Colorectal Cancer; 2008 May; 7(3):172-7. PubMed ID: 18621634
[TBL] [Abstract][Full Text] [Related]
2. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
3. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
4. Technology insight: Identification of biomarkers with tissue microarray technology.
Giltnane JM; Rimm DL
Nat Clin Pract Oncol; 2004 Dec; 1(2):104-11. PubMed ID: 16264828
[TBL] [Abstract][Full Text] [Related]
5. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
McCabe A; Dolled-Filhart M; Camp RL; Rimm DL
J Natl Cancer Inst; 2005 Dec; 97(24):1808-15. PubMed ID: 16368942
[TBL] [Abstract][Full Text] [Related]
6. Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format.
Dubé V; Grigull J; DeSouza LV; Ghanny S; Colgan TJ; Romaschin AD; Siu KW
J Proteome Res; 2007 Jul; 6(7):2648-55. PubMed ID: 17552551
[TBL] [Abstract][Full Text] [Related]
7. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
Camp RL; Neumeister V; Rimm DL
J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
[TBL] [Abstract][Full Text] [Related]
8. Tumor profiling using protein biomarker panels in malignant melanoma: application of tissue microarrays and beyond.
Joyce CW; Murphy IG; Rafferty M; Ryan D; McDermott EW; Gallagher WM
Expert Rev Proteomics; 2012 Aug; 9(4):415-23. PubMed ID: 22967078
[TBL] [Abstract][Full Text] [Related]
9. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
[TBL] [Abstract][Full Text] [Related]
11. Tissue microarrays: applications in genomic research.
Watanabe A; Cornelison R; Hostetter G
Expert Rev Mol Diagn; 2005 Mar; 5(2):171-81. PubMed ID: 15833047
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray - a high-throughput molecular analysis in head and neck cancer.
Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW
J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941
[TBL] [Abstract][Full Text] [Related]
13. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience.
Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM
Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364
[TBL] [Abstract][Full Text] [Related]
14. Validation of immature adipogenic status and identification of prognostic biomarkers in myxoid liposarcoma using tissue microarrays.
Cheng H; Dodge J; Mehl E; Liu S; Poulin N; van de Rijn M; Nielsen TO
Hum Pathol; 2009 Sep; 40(9):1244-51. PubMed ID: 19368956
[TBL] [Abstract][Full Text] [Related]
15. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
16. Translational studies for target-based drugs.
Nishio K; Arao T; Shimoyama T; Fujiwara Y; Tamura T; Saijo N
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():90-3. PubMed ID: 16273363
[TBL] [Abstract][Full Text] [Related]
17. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
Merrick BA; Bruno ME
Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
19. Design, construction, and analysis of cell line arrays and tissue microarrays for gene expression analysis.
Gately K; Kerr K; O'Byrne K
Methods Mol Biol; 2011; 784():139-53. PubMed ID: 21898218
[TBL] [Abstract][Full Text] [Related]
20. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]